📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 16:18
429 analysed today
429
Today
133,318
All-time analysed
40,105
Positive
6,279
Negative
79,121
Neutral
7,745
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
₹10.55 Cr Q1 Revenue: Integrated Proteins Exceeds Full Year FY26 Revenue in One Quarter
Integrated Proteins reported a massive scale-up in operations for Q1 FY27, with revenue from operations reaching ₹10.55 Cr, a significant jump from just ₹0.05 Cr in Q1 FY26. This single quarter's revenue has already surpassed the company's total TTM revenue of ₹10 Cr. Net profit for the quarter stood at ₹36.26 Lakhs, up from ₹19 Lakhs in the previous sequential quarter (Mar 2026). The growth is almost entirely driven by a new or expanded Textile segment, which contributed 99.6% of the total revenue.
Confidence: HIGH
What changedThe company has undergone a significant operational scale-up, primarily through its Textile segment, moving away from its historical low-revenue base.
Why it mattersFor a micro-cap company with previously negligible revenue, this sudden jump to a ₹40 Cr+ annual run rate (if sustained) represents a fundamental shift in its business profile and valuation context.
Q1 Revenue: ₹10.55 CrQ1 Net Profit: ₹36.26 LakhsTextile Segment Revenue: ₹10.51 CrRevenue vs TTM Revenue: 105.5%EPS (Q1): ₹0.19
📅 Short termThe stock may react positively to the massive top-line growth and the fact that one quarter's revenue has exceeded the previous full year.
📈 Long termThe long-term outlook depends on the company's ability to stabilize this new Textile business and address the risks associated with extremely low promoter holding (2.23%).
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Extremely low promoter holding at 2.23%
- High P/E ratio of 1130.4
- Sudden shift in business focus to Textiles from Edible Oils
Key Highlights
Revenue from operations surged to ₹10.55 Cr in Q1 FY27 from ₹0.05 Cr in Q1 FY26.
Net profit increased to ₹36.26 Lakhs, nearly doubling the ₹19 Lakhs reported in the preceding quarter.
The Textile segment contributed ₹10.51 Cr to revenue, effectively pivoting the company's business mix.
Quarterly revenue of ₹10.55 Cr represents ~105% of the total TTM revenue of ₹10 Cr.
Earnings Per Share (EPS) improved to ₹0.19 for the quarter compared to ₹0.10 in the previous quarter.
👀 What to Watch
Investors should monitor the sustainability of the Textile segment's revenue and whether the company can maintain or improve its current operating margins of ~4.6% as it scales.
Rs 10.55 Cr Q1 Revenue: Integrated Proteins exceeds FY26 annual sales in a single quarter
Integrated Proteins reported a massive scale-up in operations for Q1 FY27, with revenue from operations reaching Rs 10.55 Cr, a significant jump from Rs 0.05 Cr in the same quarter last year. This single quarter's revenue exceeds the company's total FY26 annual revenue of Rs 9.94 Cr. Net profit for the quarter rose to Rs 0.36 Cr compared to a negligible Rs 0.01 Lakhs YoY. Notably, the growth is driven by a pivot into the Textile segment, which contributed 99.6% of the total revenue.
Confidence: HIGH
What changedThe company has successfully scaled a new Textile business line, leading to a massive jump in top-line and bottom-line figures compared to its historical performance in the edible oil sector.
Why it mattersThis represents a fundamental shift in the company's operating scale; previously a micro-cap with negligible revenue, it has now demonstrated the ability to generate significant quarterly turnover.
Revenue (Q1 FY27): Rs 10.55 CrNet Profit (Q1 FY27): Rs 0.36 CrTextile Segment Revenue: Rs 10.51 CrRevenue vs TTM Revenue: ~105%Promoter Holding: 2.23%
📅 Short termThe stock is likely to react positively to the massive revenue growth and return to meaningful profitability.
📈 Long termIf the company can sustain this new run rate in the textile segment, it could lead to a structural re-rating, though the low promoter stake is a long-term governance concern.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Extremely low promoter holding (2.23%)
- Business pivot risk (shifting from Edible Oil to Textiles)
- High P/E ratio (1130.4)
Key Highlights
Revenue from operations surged to Rs 10.55 Cr in Q1 FY27 from Rs 0.05 Cr in Q1 FY26.
Net profit increased to Rs 36.26 Lakhs (Rs 0.36 Cr) from Rs 0.01 Lakhs in the previous year's quarter.
The Textile segment emerged as the primary driver, contributing Rs 10.51 Cr to the total revenue.
Quarterly revenue (Rs 10.55 Cr) represents approximately 106% of the total revenue generated in the entire FY26 (Rs 9.94 Cr).
Earnings Per Share (EPS) improved to Rs 0.19 for the quarter from Rs 0.00 YoY.
👀 What to Watch
Investors should monitor the sustainability of the new Textile segment revenue and watch for any further diversification or shifts in the core business model. The extremely low promoter holding of 2.23% remains a critical risk factor to track.
1:10 Stock Split and Management Regularisation at Integrated Proteins Ltd
Integrated Proteins Ltd has issued a notice for an Extraordinary General Meeting (EGM) on August 20, 2026, to approve a 1:10 stock split. The proposal involves sub-dividing each equity share of face value ₹10 into 10 shares of face value ₹1 each to improve liquidity. Additionally, the company seeks shareholder approval to regularise the appointments of Mr. Hiren Dhirajlal Shah as Chairman and Managing Director and Mr. Nitish Pratapray Mehta as a Non-Executive Director. This comes amid a period of high stock price volatility, with a 353% return over the last six months despite a small TTM revenue of ₹10 Cr.
Confidence: HIGH
What changedThe company is initiating a stock split to increase share liquidity and is formalizing its board leadership by regularising the Managing Director and a Non-Executive Director.
Why it mattersWhile a stock split is fundamentally neutral, it often increases retail participation in small-cap stocks. The management regularisation is a necessary corporate governance step to confirm leadership for the current fiscal year.
Stock Split Ratio: 1:10New Face Value: ₹1Authorized Capital: ₹25 CrTTM Revenue: ₹10 CrPromoter Holding: 2.23%Market Cap: ₹266 Cr
📅 Short termThe stock split news may drive short-term retail interest and liquidity, but the impact is purely technical and does not change the company's valuation or earnings potential.
📈 Long termLimited structural significance. The company's long-term value depends on its ability to scale operations beyond the current ₹10 Cr TTM revenue and improve its low operating margins (2.4%).
⚠ Risk flags
- Extremely low promoter holding (2.23%)
- Very high P/E ratio (1208.3)
- Small revenue base relative to market capitalization
Key Highlights
Proposed stock split of 1 equity share (face value ₹10) into 10 equity shares (face value ₹1).
EGM scheduled for August 20, 2026, at 1:00 PM via Video Conferencing.
Authorized Share Capital to be reclassified into 25,00,00,000 equity shares of ₹1 each, maintaining the total at ₹25 Cr.
Regularisation of Mr. Hiren Dhirajlal Shah as CMD following his initial appointment on July 9, 2026.
Promoter holding remains exceptionally low at 2.23% as of the latest March 2026 filing.
👀 What to Watch
Investors should monitor the EGM voting results on August 20 and the subsequent announcement of the record date for the stock split. Given the extremely high P/E of 1208x and low promoter holding, focus on actual revenue growth in upcoming quarterly results.
Integrated Proteins Redesignates Hiren Shah as CMD for 5-Year Term
Integrated Proteins Ltd has approved the redesignation of Mr. Hiren Shah from Additional Executive Director to Chairman and Managing Director (CMD) for a five-year term starting July 24, 2026. This leadership change comes at a time when the company maintains a very small financial scale, with TTM revenue of just ₹10 Cr and a high P/E ratio of 1175.0. The appointment is subject to shareholder approval at an Extra-Ordinary General Meeting (EGM) scheduled for August 20, 2026. Investors should note the significant decline in promoter holding, which stood at 2.23% in March 2026 compared to 13.04% in September 2025.
Confidence: HIGH
What changedMr. Hiren Shah has been elevated from Additional Executive Director to the role of Chairman and Managing Director, subject to shareholder approval.
Why it mattersFormalises the top leadership for a five-year period, providing administrative stability for a micro-cap company currently trading at an extremely high valuation relative to its earnings.
Tenure: 5 yearsEGM Date: August 20, 2026Promoter Holding: 2.23%TTM Revenue: ₹10 CrP/E Ratio: 1175.0
📅 Short termThe market is likely to remain focused on the upcoming EGM and voting results; however, the administrative nature of the change suggests limited immediate price impact based on fundamentals.
📈 Long termThe long-term outlook depends on the new CMD's ability to scale operations beyond the current ₹10 Cr revenue base and justify the ₹258 Cr market capitalization.
⚠ Risk flags
- Extremely low promoter holding (2.23%)
- Very high P/E ratio (1175.0)
- Small revenue base and low operating margins
Key Highlights
Mr. Hiren Shah redesignated as Chairman and Managing Director for a 5-year term ending July 23, 2031
Extra-Ordinary General Meeting (EGM) to be held on August 20, 2026, via video conferencing
Cut-off date for e-voting eligibility set for August 13, 2026
Promoter holding has dropped significantly to 2.23% as of the latest March 2026 filing
Company reported a TTM revenue of ₹10 Cr with a thin operating margin of 2.4%
👀 What to Watch
Monitor the voting results of the EGM on August 20, 2026, and watch for any strategic shifts under the formalised leadership to address the company's low revenue and high valuation.
Hiren Dhirajlal Shah Appointed as Chairman and Managing Director for 5-Year Term
Integrated Proteins Ltd has re-designated Hiren Dhirajlal Shah as Chairman and Managing Director for a five-year term effective July 24, 2026, through July 23, 2031. This leadership change is subject to shareholder approval at an Extra-Ordinary General Meeting (EGM) scheduled for August 20, 2026. The company currently operates with a very low promoter holding of 2.23% and reported a TTM revenue of just Rs 10 Cr. Investors should note the e-voting cut-off date of August 13, 2026, to participate in the approval process.
Confidence: HIGH
What changedHiren Dhirajlal Shah has been elevated from Additional Executive Director to the role of Chairman and Managing Director.
Why it mattersThe appointment provides a 5-year leadership mandate for a micro-cap company (Rs 258 Cr market cap) that is currently struggling with low profitability and minimal promoter ownership.
Appointment Term: 5 YearsEGM Date: August 20, 2026Promoter Holding: 2.23%TTM Revenue: Rs 10 CrTTM PAT: Rs 0 Cr
📅 Short termThe stock may see limited reaction as this is a procedural leadership formalization; focus will be on the EGM outcome in late August.
📈 Long termLeadership stability is established for 5 years, but the structural risks of low promoter skin-in-the-game and weak financial metrics (ROCE 1.3%) remain the primary long-term concerns.
⚠ Risk flags
- Extremely low promoter holding (2.23%)
- Stagnant profitability (TTM PAT Rs 0 Cr)
- High valuation relative to earnings (P/E 1175.0)
Key Highlights
Appointment of Hiren Dhirajlal Shah as CMD for a fixed 5-year term until July 23, 2031
Extra-Ordinary General Meeting (EGM) convened for August 20, 2026, to seek shareholder approval
Cut-off date for e-voting eligibility set for August 13, 2026
E-voting period scheduled from August 17, 2026 (9:00 AM) to August 19, 2026 (5:00 PM)
Company maintains a low promoter holding of 2.23% as of March 2026
👀 What to Watch
Monitor the EGM voting results on August 20, 2026, and watch for any strategic shifts or capital allocation plans from the new CMD to address the company's stagnant TTM PAT of Rs 0 Cr.
